Synonyms: compound 37 [PMID: 33109399] | CYH-33 | CYH33
Compound class:
Synthetic organic
Comment: This is the chemical structure for the INN risovalisib. It maps to the PI3Kα inhibitor CYH33, which is an orally bioavailable and selective inhibitor that was developed for anti-tumour potential [1].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Risovalisib (CYH33; compound 37) inhibits phosphorylation of AKT in human cancer cells, which is indicative of its disruption of the cellular PI3K/AKT/mTOR pathway. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|